Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of amniotic membrane extract versus autologous serum eyedrops for severe dry eye disease
2011-006287-50Phase 3Terminated
- Sponsor
- Clínica Universidad de Navarra
- Start
- Jan 2012
- Countries
- 1
01
Overview
Phase 3 trial of amniotic membrane extract in dry eye syndrome (DED) (2 arms), sponsored by Clínica Universidad de Navarra. Primary endpoint: Tear volume and clearance. Started Jan 2012; status: terminated.
02
Drugs
amniotic membrane extract
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2011-006287-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006287-50.